![Bob van Gemen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bob van Gemen
Director/Board Member at Genome Diagnostics BV
Bob van Gemen active positions
Companies | Position | Start | End |
---|---|---|---|
Genome Diagnostics BV
![]() Genome Diagnostics BV Medical SpecialtiesHealth Technology Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands. | Director/Board Member | 2021-07-31 | - |
Career history of Bob van Gemen
Former positions of Bob van Gemen
Companies | Position | Start | End |
---|---|---|---|
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Chief Executive Officer | 2011-10-31 | 2020-07-31 |
AKZO NOBEL N.V. | Corporate Officer/Principal | - | - |
PrimaGen Holding BV
![]() PrimaGen Holding BV Miscellaneous Commercial ServicesCommercial Services PrimaGen Holding BV designs and develops molecular diagnostic tests. The firm conducts tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring, DFS paper technology, oncology and virus discovery. It also develops in monitoring toxic side effects of antiviral medication and for diagnosing and monitoring certain forms of cancer. The company was founded in November 2001 and is headquartered in Amsterdam, the Netherlands. | Chief Executive Officer | - | - |
Training of Bob van Gemen
University of Leiden | Doctorate Degree |
Statistics
International
Netherlands | 6 |
Operational
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AKZO NOBEL N.V. | Process Industries |
Private companies | 3 |
---|---|
PrimaGen Holding BV
![]() PrimaGen Holding BV Miscellaneous Commercial ServicesCommercial Services PrimaGen Holding BV designs and develops molecular diagnostic tests. The firm conducts tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring, DFS paper technology, oncology and virus discovery. It also develops in monitoring toxic side effects of antiviral medication and for diagnosing and monitoring certain forms of cancer. The company was founded in November 2001 and is headquartered in Amsterdam, the Netherlands. | Commercial Services |
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Health Technology |
Genome Diagnostics BV
![]() Genome Diagnostics BV Medical SpecialtiesHealth Technology Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Bob van Gemen
- Experience